Status:
COMPLETED
Efficacy of Zinc in the Treatment of Bronchiolitis and Prevention of Wheezing Respiratory Illness in Children Less Than Two Years Old
Lead Sponsor:
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborating Sponsors:
United States Agency for International Development (USAID)
Conditions:
Bronchiolitis
Eligibility:
All Genders
2-23 years
Phase:
PHASE3
Brief Summary
1\. Bronchiolitis is a leading cause of morbidity and mortality in children. It is an acute, infectious illness of the lower respiratory tract resulting in obstruction of the bronchioles. The etiology...
Eligibility Criteria
Inclusion
- Children 2 months to 23 months old at the time of clinical diagnosis· Episode of wheezing for the first time Written consent· Who do not require hospitalization at the time of diagnosis
Exclusion
- History of asthma Chronic cardiac or respiratory disease (e.g.cyanotic heart disease -ASD) History of previous wheezing or bronchodilator therapy Gestational age at birth \<34 weeks Suspected tuberculosis, active measles Any illness (severe malnutrition, sepsis, meningitis) that requires hospitalisation Who had zinc/placebo supplements during this study· H/o zinc intake within last 3 months· Whose caretakers withhold consent
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2007
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT00355043
Start Date
February 1 2006
End Date
September 1 2007
Last Update
July 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICDDR,B
Dhaka, Bangladesh, 1212